VivaGel® BV has been granted regulatory approval in Australia by the TGA and is expected to be available over-the-counter in pharmacies in 2019, and marketed under the brand name Fleurstat BV Gel by Aspen Pharmacare.
VivaGel® BV for the treatment and symptomatic relief of BV has been granted regulatory approval in the EU.
Regulatory processes are underway to enable marketing in the US and other geographic regions.
The VivaGel® condom has been launched in Australia and Canada under the LifeStyles® Dual Protect™ brand.
VivaGel®, in a gel formulation for management of BV and STI prevention, is currently not available for sale in any countries.
It has come to the attention of Starpharma that a group of Malaysian companies, identified as LJC marketing, SWB, Women Beauty Supplies and JSW Millenium Enterprises are marketing a product named “VIVAgel”, "VIVA balance Microbicide Gel" and “VIVA Microbicide GEL” with the package bearing the mark "VIVAgel". The company uses the Alibaba website to advertise this product.
- Starpharma has no relationship with these companies or this product and is taking steps to have the activity discontinued.
- This product is not Starpharma's VivaGel® product and does not contain VivaGel®(SPL7013, astodrimer sodium).